Viewing Study NCT02945267

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-02-06 @ 8:19 AM
Study NCT ID: NCT02945267
Status: UNKNOWN
Last Update Posted: 2016-10-26
First Post: 2016-10-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer
Sponsor: Chinese PLA General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pancreatic Cancer View
None Unresectable View
None Maintenance Treatment View